Garg, Vikas
Oza, Amit M.
Funding for this research was provided by:
PM Cancer Foundation
Article History
Accepted: 19 August 2023
First Online: 22 September 2023
Declarations
:
: The authors are supported by the Princess Margaret Cancer Foundation.
: Amit M. Oza: PI and Steering Committees with AstraZeneca and GSK; advisory boards for Merck (uncompensated) and Morphosys; and Chief Executive Officer at Ozmosis Research (uncompensated). Vikas Garg reports no conflicts of interest.
: Not applicable.
: Not applicable.
: Not applicable.
: No datasets were generated or analysed during the current study.
: VG made substantial contributions to the concept and design of the work and approved the final version to be published. AMO revised the work critically for important intellectual content and approved the final version to be published.